[NH2Me2][(RuCl((R)-segphos(regR)))2(mu-Cl)3]200mg

(S)-(-)-Pyrotartaric acid, 97.0%, 10g

(2R,3R,4S,5S,6R)-2-[(2S,3S,4R,5R)-4-Hydroxy-2,5-bis(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol, 99+%, 500mg

3-Chloro-5H-pyrrolo[3,2-c]pyridazine, 98%, 250mg

4-[(2-Chlorophenyl)amino]-4-oxobutanoic acid, 95.0%, 500mg

2-Methyl-5-nitropyridine>96.0%(GC)(T)1g

(2R,6R)-2,6-Dimethylpiperazine dihydrochloride, 95.0%, 25g

2,5-Dibromo-isonicotinic acid, 97.0%, 25g

3-Bromo-4,5-dimethylnitrobenzene, 95.0%, 5g

4-Amino-2-chloropyrimidine-5-carbaldehyde, 97%, 100mg

6-Ethoxy-2-hydrazinylbenzo[d]thiazole, 95.0%, 1g

3-Fluoro-4-methyl-5-hydroxybenzoic acid, 95.0%, 250mg

TERT-BUTYL 2-(2-METHOXY-2-OXOETHYL)PIPERAZINE-1-CARBOXYLATE, 95%, 100mg